These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6421463)

  • 1. [Presence of the terminal complement activation complex (C5b-9) on cell remnants within connective matrices of normal human kidney].
    Bariety J; Hinglais N; Bhakdi S; Kazatchkine M
    C R Seances Acad Sci III; 1983; 297(9):459-61. PubMed ID: 6421463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
    Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
    Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases.
    Rus HG; Niculescu F; Nanulescu M; Cristea A; Florescu P
    Clin Exp Immunol; 1986 Jul; 65(1):66-72. PubMed ID: 3539428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy.
    Lai KN; Lo ST; Lai FM
    Am J Pathol; 1989 Sep; 135(3):469-76. PubMed ID: 2675624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.
    Schäfer H; Mathey D; Hugo F; Bhakdi S
    J Immunol; 1986 Sep; 137(6):1945-9. PubMed ID: 3528291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
    Carney DF; Koski CL; Shin ML
    J Immunol; 1985 Mar; 134(3):1804-9. PubMed ID: 3968432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of the terminal C5b-9 complement complexes associated to S-protein and macrophage immunoreactive deposits in human damaged myocardial areas.
    Vlaicu R; Rus HG; Niculescu F
    Med Interne; 1988; 26(1):21-7. PubMed ID: 3399815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.
    Niculescu F; Hugo F; Rus HG; Vlaicu R; Bhakdi S
    Clin Exp Immunol; 1987 Aug; 69(2):477-83. PubMed ID: 3652536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular deposition of complement membrane attack complex in dermatomyositis.
    Kissel JT; Mendell JR; Rammohan KW
    N Engl J Med; 1986 Feb; 314(6):329-34. PubMed ID: 3945256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
    Hakulinen J; Meri S
    Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy.
    Hafer-Macko CE; Sheikh KA; Li CY; Ho TW; Cornblath DR; McKhann GM; Asbury AK; Griffin JW
    Ann Neurol; 1996 May; 39(5):625-35. PubMed ID: 8619548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural localization of the membrane attack complex of complement in human renal tissues.
    Falk RJ; Sisson SP; Dalmasso AP; Kim Y; Michael AF; Vernier RL
    Am J Kidney Dis; 1987 Feb; 9(2):121-8. PubMed ID: 3548335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of complement membrane attack complex formation in myocardial infarction.
    Väkevä A; Laurila P; Meri S
    Am J Pathol; 1993 Jul; 143(1):65-75. PubMed ID: 7686345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the anti-erythrocyte immune response in mice by the C5b--9 complex of complement.
    Horn W; Opferkuch W; Podack ER
    Immunology; 1981 Jun; 43(2):303-9. PubMed ID: 7019052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque.
    Rus HG; Niculescu F; Constantinescu E; Cristea A; Vlaicu R
    Atherosclerosis; 1986 Jul; 61(1):35-42. PubMed ID: 3524587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced B7-H1 expression on human renal tubular epithelial cells by the sublytic terminal complement complex C5b-9.
    Chen Y; Zhang J; Guo G; Ruan Z; Jiang M; Wu S; Guo S; Fei L; Tang Y; Yang C; Jia Z; Wu Y
    Mol Immunol; 2009 Jan; 46(3):375-83. PubMed ID: 19081139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.
    Falk RJ; Podack E; Dalmasso AP; Jennette JC
    Am J Pathol; 1987 Apr; 127(1):182-90. PubMed ID: 2952015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart.
    Homeister JW; Satoh PS; Kilgore KS; Lucchesi BR
    J Immunol; 1993 Feb; 150(3):1055-64. PubMed ID: 8423331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.